688581 安杰思
已收盘 08-13 15:00:01
资讯
新帖
简况
【机构调研记录】国寿安保基金调研安杰思、炬申股份等3只个股(附名单)
证券之星 · 08:12
【机构调研记录】国寿安保基金调研安杰思、炬申股份等3只个股(附名单)
【机构调研记录】华泰保兴基金调研九号公司、安杰思
证券之星 · 08:12
【机构调研记录】华泰保兴基金调研九号公司、安杰思
【私募调研记录】高信百诺调研安杰思
证券之星 · 08:12
【私募调研记录】高信百诺调研安杰思
【私募调研记录】名禹资产调研安杰思、恒逸石化
证券之星 · 08:12
【私募调研记录】名禹资产调研安杰思、恒逸石化
股市必读:安杰思(688581)8月12日披露最新机构调研信息
证券之星 · 02:28
股市必读:安杰思(688581)8月12日披露最新机构调研信息
安杰思:深圳前海微众银行股份有限公司、中泰证券等多家机构于8月10日调研我司
证券之星 · 08-12 18:03
安杰思:深圳前海微众银行股份有限公司、中泰证券等多家机构于8月10日调研我司
安杰思(688581)6月30日股东户数0.47万户,较上期减少23.89%
证券之星 · 08-07
安杰思(688581)6月30日股东户数0.47万户,较上期减少23.89%
图解安杰思中报:第二季度单季净利润同比下降12.10%
证券之星 · 08-07
图解安杰思中报:第二季度单季净利润同比下降12.10%
安杰思(688581.SH)发布半年度业绩,归母净利润1.18亿元,同比下降6.27%
智通财经 · 08-06
安杰思(688581.SH)发布半年度业绩,归母净利润1.18亿元,同比下降6.27%
安杰思获得发明专利授权:“一种端部执行器械及操作方法”
证券之星 · 08-01
安杰思获得发明专利授权:“一种端部执行器械及操作方法”
安杰思获得实用新型专利授权:“一种组织切开装置”
证券之星 · 07-31
安杰思获得实用新型专利授权:“一种组织切开装置”
股市必读:安杰思(688581)7月27日董秘有最新回复
证券之星 · 07-28
股市必读:安杰思(688581)7月27日董秘有最新回复
安杰思获得发明专利授权:“电外科工作站、电外科工作站的控制方法及电外科设备”
证券之星 · 07-15
安杰思获得发明专利授权:“电外科工作站、电外科工作站的控制方法及电外科设备”
安杰思(688581)披露股东减持计划时间届满暨减持股份结果公告,7月13日股价下跌2.53%
证券之星 · 07-13
安杰思(688581)披露股东减持计划时间届满暨减持股份结果公告,7月13日股价下跌2.53%
每周股票复盘:安杰思(688581)注销38万股员工持股计划
证券之星 · 07-12
每周股票复盘:安杰思(688581)注销38万股员工持股计划
安杰思(688581)披露2025年员工持股计划注销实施公告,7月9日股价下跌1.78%
证券之星 · 07-09
安杰思(688581)披露2025年员工持股计划注销实施公告,7月9日股价下跌1.78%
每周股票复盘:安杰思(688581)变更持续督导保荐代表人
证券之星 · 05-31
每周股票复盘:安杰思(688581)变更持续督导保荐代表人
安杰思(688581)披露关于变更保荐代表人的公告,5月29日股价下跌1.98%
证券之星 · 05-29
安杰思(688581)披露关于变更保荐代表人的公告,5月29日股价下跌1.98%
每周股票复盘:安杰思(688581)终止员工持股计划并减资
证券之星 · 05-17
每周股票复盘:安杰思(688581)终止员工持股计划并减资
安杰思(688581)披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告,5月15日股价下跌2.7%
证券之星 · 05-15
安杰思(688581)披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告,5月15日股价下跌2.7%
加载更多
公司概况
公司名称:
杭州安杰思医学科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2023-05-19
主营业务:
杭州安杰思医学科技股份有限公司的主营业务是内镜微创诊疗器械的研发、生产与销售。公司的主要产品是止血闭合类、圈套器类、ESD治疗器械、胆胰治疗类、基础治疗类、复用内窥镜。公司获得多项政府荣誉,主要包括“浙江省高新技术企业创新能力500强”、“一种可旋转止血夹”专利浙江省人民政府质量奖(省知识产权奖)专利奖三等奖、2025年度临平智造新质生产力等奖项。
发行价格:
125.80
{"stockData":{"symbol":"688581","market":"SH","secType":"STK","nameCN":"安杰思","latestPrice":53.84,"timestamp":1786604401000,"preClose":53.11,"halted":0,"volume":1341325,"delay":0,"changeRate":0.0137,"floatShares":41178300,"shares":80740700,"eps":2.6482,"marketStatus":"已收盘","change":0.73,"latestTime":"08-13 15:00:01","open":53.5,"high":55.11,"low":53.01,"amount":72688400,"amplitude":0.0395,"askPrice":53.85,"askSize":9,"bidPrice":53.84,"bidSize":16,"shortable":0,"etf":0,"ttmEps":2.6482,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"adjPreClose":53.11,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":58.42,"lowLimit":47.8,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":80740656,"isCdr":false,"pbRate":1.71,"roa":"--","peRate":20.330791,"roe":"4.62%","epsLYR":2.76,"committee":0.183099,"marketValue":4347000000,"turnoverRate":0.0326,"status":0,"afterMarket":{"amount":0,"volume":0,"close":53.84,"buyVolume":0,"sellVolume":0,"time":1786606437746,"indexStatus":"已收盘 08-13 15:30:00","preClose":53.11},"floatMarketCap":2217000000},"requestUrl":"/m/hq/s/688581","defaultTab":"news","newsList":[{"id":"2659189293","title":"【机构调研记录】国寿安保基金调研安杰思、炬申股份等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659189293?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:12","pubTimestamp":1786579954,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月12日披露的机构调研信息,国寿安保基金近期对3家上市公司进行了调研,相关名单如下:1)安杰思 调研纪要:公司泰国工厂二期建设有序推进,预计2027年上半年投产。2)炬申股份 调研纪要:公司本次可转债发行已经完成,将在8月13日上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300005974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581","BK0237","001202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659189419","title":"【机构调研记录】华泰保兴基金调研九号公司、安杰思","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659189419?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:12","pubTimestamp":1786579948,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月12日披露的机构调研信息,华泰保兴基金近期对2家上市公司进行了调研,相关名单如下:1)九号公司 调研纪要:2026年上半年电动两轮车毛利率受原材料上涨及产品结构变化影响,7月起通过提价缓解压力,三季度出货量大,电自占比提升。2)安杰思 调研纪要:公司泰国工厂二期建设有序推进,预计2027年上半年投产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300005966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659892171","title":"【私募调研记录】高信百诺调研安杰思","url":"https://stock-news.laohu8.com/highlight/detail?id=2659892171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659892171?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:12","pubTimestamp":1786579935,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月12日披露的机构调研信息,知名私募高信百诺近期对1家上市公司进行了调研,相关名单如下:1)安杰思 调研纪要:公司泰国工厂二期建设有序推进,预计2027年上半年投产。单双极电刀已获证,集采落地后有望带来新增量。机构简介:北京高信百诺投资管理有限公司是一家成立于2009年的以证券投资为主要业务的专业投资机构,注册资本1111.11万。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081300005945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659818929","title":"【私募调研记录】名禹资产调研安杰思、恒逸石化","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659818929?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:12","pubTimestamp":1786579934,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月12日披露的机构调研信息,知名私募名禹资产近期对2家上市公司进行了调研,相关名单如下:1)安杰思 调研纪要:公司泰国工厂二期建设有序推进,预计2027年上半年投产。机构简介:上海名禹资产管理有限公司成立于2009年9月9日,注册资本2000万元,是一家专注于股票二级市场投资的专业投资机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081300005943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","BK0025","BK0185","000703","688581","BK0196","BK0208","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902826","title":"股市必读:安杰思(688581)8月12日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659902826?lang=zh_cn&edition=full","pubTime":"2026-08-13 02:28","pubTimestamp":1786559293,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,安杰思报收于53.11元,下跌0.04%,换手率1.2%,成交量4929.0手,成交额2612.44万元。机构调研要点:第七批消化内镜耗材国采已于2026年6月由天津市医药采购中心牵头正式启动,进入正式落地阶段。机构调研要点8月10日特定对象调研泰国工厂二期建设项目已正式启动,已完成土地购置、厂房规划设计及核心设备选型采购,土建工程按计划有序施工,预计2027年上半年建成投产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658757429","title":"安杰思:深圳前海微众银行股份有限公司、中泰证券等多家机构于8月10日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658757429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658757429?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:03","pubTimestamp":1786529009,"startTime":"0","endTime":"0","summary":"报告期内,海外业务实现销售收入 2.01 亿元,同比增长 23.81%。其中,公司在北美、亚太及大洋洲地区销售增长较快。公司预计将于 2026 年下半年正式上市销售,为公司贡献新的收入增量。该股最近90天内共有4家机构给出评级,买入评级2家,增持评级2家。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200032610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","600918","BK0251","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661194","title":"安杰思(688581)6月30日股东户数0.47万户,较上期减少23.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661194","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657661194?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:38","pubTimestamp":1786095516,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安杰思披露,截至2026年6月30日公司股东户数为4712.0户,较3月31日减少1479.0户,减幅为23.89%。在医疗器械行业个股中,安杰思股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.14万户。从股价来看,2026年3月31日至2026年6月30日,安杰思区间跌幅为1.81%,在此期间股东户数减少1479.0户,减幅为23.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565937","title":"图解安杰思中报:第二季度单季净利润同比下降12.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565937?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:13","pubTimestamp":1786036422,"startTime":"0","endTime":"0","summary":"证券之星消息,安杰思2026年中报显示,上半年度公司主营收入3.02亿元,同比下降0.28%;归母净利润1.18亿元,同比下降6.27%;扣非净利润9953.73万元,同比下降10.73%;其中2026年第二季度,公司单季度主营收入1.61亿元,同比下降7.31%;单季度归母净利润6132.69万元,同比下降12.1%;单季度扣非净利润5083.87万元,同比下降19.11%;负债率6.66%,投资收益1855.62万元,财务费用363.06万元,毛利率71.52%。财报数据概要请见下图:本文数据来源于安杰思2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063244","title":"安杰思(688581.SH)发布半年度业绩,归母净利润1.18亿元,同比下降6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063244","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657063244?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:29","pubTimestamp":1786022964,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安杰思(688581.SH)披露2026年半年度报告,报告期公司实现营收3.02亿元,同比下降0.28%;归属于上市公司股东的净利润1.18亿元,同比下降6.27%;扣非净利润9954万元,同比下降10.73%;基本每股收益1.4565元。报告期内,随着国内集采政策不断落地,利润端承压。公司仍不断推进国内医院临床的渗透率,同时积极拓展海外合作渠道。在国内市场方面,公司持续加大研发投入,优化产品结构,推动产品迭代创新,以满足临床多样化需求。公司紧密跟踪行业政策动态,及时调整市场策略,积极应对集采带来的挑战,努力在价格竞争与价值创造之间寻求平衡。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656639640","title":"安杰思获得发明专利授权:“一种端部执行器械及操作方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2656639640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656639640?lang=zh_cn&edition=full","pubTime":"2026-08-01 03:38","pubTimestamp":1785526715,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安杰思新获得一项发明专利授权,专利名为“一种端部执行器械及操作方法”,专利申请号为CN202311083814.1,授权日为2026年7月31日。今年以来安杰思新获得专利授权18个,较去年同期增加了80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080100003639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655388136","title":"安杰思获得实用新型专利授权:“一种组织切开装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2655388136","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655388136?lang=zh_cn&edition=full","pubTime":"2026-07-31 03:26","pubTimestamp":1785439588,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安杰思新获得一项实用新型专利授权,专利名为“一种组织切开装置”,专利申请号为CN202521258163.X,授权日为2026年7月31日。今年以来安杰思新获得专利授权16个,较去年同期增加了60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100004028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654042865","title":"股市必读:安杰思(688581)7月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654042865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654042865?lang=zh_cn&edition=full","pubTime":"2026-07-28 01:27","pubTimestamp":1785173232,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘,安杰思报收于50.8元,上涨1.07%,换手率0.72%,成交量2953.0手,成交额1497.39万元。董秘最新回复投资者: 请问,截至2026年6月30日公司的股东总数是多少?根据《上海证券交易所科创板股票上市规则》及公司信息披露安排,公司将在定期报告中披露并持续更新,请关注公司后续披露的定期报告。当日关注点交易信息汇总:7月27日主力资金净流入191.23万元,游资资金净流入140.51万元,散户资金净流出331.74万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800000779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651304486","title":"安杰思获得发明专利授权:“电外科工作站、电外科工作站的控制方法及电外科设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2651304486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651304486?lang=zh_cn&edition=full","pubTime":"2026-07-15 03:27","pubTimestamp":1784057224,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安杰思新获得一项发明专利授权,专利名为“电外科工作站、电外科工作站的控制方法及电外科设备”,专利申请号为CN202210969413.5,授权日为2026年7月14日。相比于现有技术,本发明采用切换的方式能够实现工作站模式的快速切换,且电路的复杂度较低,减小电外科工作站的体积,提高电外科工作站的输出稳定性。今年以来安杰思新获得专利授权14个,较去年同期增加了75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500004902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711110","title":"安杰思(688581)披露股东减持计划时间届满暨减持股份结果公告,7月13日股价下跌2.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711110","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651711110?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:54","pubTimestamp":1783954453,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘,安杰思报收于51.56元,较前一交易日下跌2.53%,最新总市值为41.83亿元。该股当日开盘52.73元,最高52.94元,最低51.4元,成交额达1809.62万元,换手率为0.84%。近日,安杰思发布《关于股东减持计划时间届满暨减持股份结果公告》。截至减持计划届满日,新建元未实施任何减持,合计减持0股,仍持有公司股份2,888,019股,占总股本3.5601%。本次减持计划已按期结束,实际减持情况与披露计划一致,未违反相关承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650544571","title":"每周股票复盘:安杰思(688581)注销38万股员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2650544571","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650544571?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:46","pubTimestamp":1783795570,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,安杰思报收于52.9元,较上周的56.2元下跌5.87%。本周,安杰思7月6日盘中最高价报56.48元。本周关注点公司公告汇总:安杰思终止2025年员工持股计划,注销381,423股股份。本次注销股份将于2026年7月14日完成,公司总股本将由81,122,079股变更为80,740,656股。注销后,控股股东及其一致行动人持股比例由48.77%被动上升至49.00%。本次注销不会对公司财务状况、经营成果及上市地位产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650920050","title":"安杰思(688581)披露2025年员工持股计划注销实施公告,7月9日股价下跌1.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650920050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650920050?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:30","pubTimestamp":1783607432,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘,安杰思报收于52.0元,较前一交易日下跌1.78%,最新总市值为42.18亿元。近日,安杰思发布《关于2025年员工持股计划注销实施的公告》。公告显示,杭州安杰思医学科技股份有限公司因市场环境变化,决定终止2025年员工持股计划,并注销已回购的381,423股股份。本次注销股份将于2026年7月14日完成,公司总股本将由81,122,079股变更为80,740,656股。注销后,控股股东及其一致行动人持股比例由48.77%被动上升至49.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639046786","title":"每周股票复盘:安杰思(688581)变更持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2639046786","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639046786?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:14","pubTimestamp":1780168452,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,安杰思报收于55.99元,较上周的61.86元下跌9.49%。变更后,公司持续督导保荐代表人为杨波先生和余启东先生,持续督导期至2026年12月31日。本次变更不影响此前保荐机构及保荐代表人所出具文件的真实性和准确性,相关责任仍由其承担。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673711","title":"安杰思(688581)披露关于变更保荐代表人的公告,5月29日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673711","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639673711?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:26","pubTimestamp":1780064779,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,安杰思报收于55.99元,较前一交易日下跌1.98%,最新总市值为45.42亿元。该股当日开盘57.12元,最高57.3元,最低55.6元,成交额达3799.07万元,换手率为1.63%。近日,杭州安杰思医学科技股份有限公司收到中信证券关于更换持续督导保荐代表人的函,原保荐代表人徐峰先生因工作安排不再负责公司持续督导工作,中信证券委派杨波先生接替其职务。本次变更不影响此前保荐机构及保荐代表人所出具文件的真实性和准确性,相关责任仍由其承担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636705064","title":"每周股票复盘:安杰思(688581)终止员工持股计划并减资","url":"https://stock-news.laohu8.com/highlight/detail?id=2636705064","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636705064?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:52","pubTimestamp":1778961132,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,安杰思报收于62.62元,较上周的63.38元下跌1.2%。本周关注点公司公告汇总:安杰思终止2025年员工持股计划并注销381,423股股票,注册资本将由81,122,079元减少至80,740,656元。安杰思关于注销2025年员工持股计划全部股票并减少注册资本暨通知债权人的公告杭州安杰思医学科技股份有限公司于2026年4月21日和5月15日分别召开董事会及年度股东大会,审议通过终止实施2025年员工持股计划并回购注销全部股票的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635603306","title":"安杰思(688581)披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告,5月15日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635603306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635603306?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:46","pubTimestamp":1778856376,"startTime":"0","endTime":"0","summary":"近日,杭州安杰思医学科技股份有限公司披露《关于注销2025年员工持股计划全部股票并减少注册资本暨通知债权人的公告》。公告显示,公司于2026年4月21日和5月15日分别召开董事会及年度股东大会,审议通过终止实施2025年员工持股计划并回购注销全部股票的议案。公司将注销已终止员工持股计划涉及的381,423股股票,注册资本由81,122,079元减少至80,740,656元,股本总额由81,122,079股减少至80,740,656股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786607521969,"stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":0.0301},{"period":"3month","weight":-0.159},{"period":"6month","weight":-0.1083},{"period":"1year","weight":-0.3624},{"period":"ytd","weight":-0.0768}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安杰思医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"4712人(较上一季度减少23.89%)","perCapita":"8739股","listingDate":"2023-05-19","address":"浙江省杭州市临平区兴中路389号","registeredCapital":"8074万元","survey":" 杭州安杰思医学科技股份有限公司的主营业务是内镜微创诊疗器械的研发、生产与销售。公司的主要产品是止血闭合类、圈套器类、ESD治疗器械、胆胰治疗类、基础治疗类、复用内窥镜。公司获得多项政府荣誉,主要包括“浙江省高新技术企业创新能力500强”、“一种可旋转止血夹”专利浙江省人民政府质量奖(省知识产权奖)专利奖三等奖、2025年度临平智造新质生产力等奖项。","listedPrice":125.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安杰思(688581)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安杰思(688581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安杰思,688581,安杰思股票,安杰思股票老虎,安杰思股票老虎国际,安杰思行情,安杰思股票行情,安杰思股价,安杰思股市,安杰思股票价格,安杰思股票交易,安杰思股票购买,安杰思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安杰思(688581)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安杰思(688581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}